Growth hormone releasing hormone analog with extended half-life for sustained GH elevation.
Synthetic GHRH analog that stimulates pituitary GH release. DAC (Drug Affinity Complex) version binds to albumin, extending half-life to 6-8 days. No-DAC version has ~30 min half-life.
Phase 2 trials demonstrate sustained IGF-1 elevation for 6+ days with DAC version. Shown to increase GH levels 2-10x baseline. Generally well-tolerated.
No-DAC: 100mcg 2-3x daily. DAC version: 1-2mg once weekly. Often combined with ipamorelin for synergistic effect.
No documented drug interactions on file.
Not FDA approved. Available through compounding pharmacies with prescription.
Available through compounding pharmacies with valid prescription.
Regulatory data last verified 4/17/2026